Microsoft Set to Monetize GenAI, Its Multi-Cloud Security Capabilities Underrated: Analysts

Microsoft Corp (NASDAQ: MSFT) stock is trading higher Thursday, with at least two analysts boosting their price target.

Microsoft Corp (NASDAQ:MSFT) stock is trading higher Thursday, with at least two analysts boosting their price target.

Mizuho analyst Gregg Moskowitz maintains Microsoft with a Buy and raises the price target from $340 to $360.

Mizuho recently hosted its 5th Annual Cybersecurity Summit. Several influential public and private security companies, including MSFT, participated in this 1-day event. The analyst provided his key takeaways from the discussion.

Jonathan Neilson, General Manager and CFO of Security, believes MSFT articulated a well-rounded cybersecurity platform well positioned to capitalize on the growing demand for security technologies.

Neilson indicated that MSFT continues to take a share in many notable areas of cybersecurity, in part by driving more consolidation with a superior TCO for customers. 

Neilson views Security Copilot as a standalone monetizable opportunity for MSFT and believes this new solution should help organizations better combat the ongoing talent shortage within the cybersecurity industry. 

Neilson also said that MSFT’s multi-cloud security capabilities are largely underappreciated and noted that the company had worked hard in this area.

Moskowitz remains encouraged by MSFT’s ongoing cybersecurity innovation; more broadly, we believe the company is ready to capitalize on Generative AI.

The re-rating reflects even more confidence in MSFT’s ability to monetize GenAI.

JP Morgan analyst Mark Murphy maintains Microsoft with an Overweight, raising the price target from $315 to $350.

AI is driving platform transformation & business model innovation.

The analyst sees a fast-growing path to $10 billion in AI business.

Price Action: MSFT shares traded higher by 2.46% at $345.58 on the last check Thursday.

Total
0
Shares
Related Posts
Read More

Scilex Holding Preliminary Q1 Net Sales For ZTlido Were $12M-$13M; Q1 Gross Sales For ZTlido Were $34M-$38M; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute

SCLX

Read More

Qualcomm’s Snapdragon 8 Gen 3 To Power 1st Galaxy AI Smartphones, Galaxy S24 Series

Discover the Future of Mobile Innovation with Qualcomm: Snapdragon 8 Gen 3 Powers Samsung Galaxy S24 Series. Qualcomm Technologies, Inc. elevates mobile technology, launching the Snapdragon 8 Gen 3 Mobile Platform in Samsung's flagship Galaxy S24 Ultra globally, and in the S24 Plus and S24 in select regions. Experience unparalleled AI capabilities and performance efficiency in the latest Galaxy S24 series, a testament to Qualcomm's leading-edge technology.

QCOM